InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the detailed record of transactions filed by BATE KENNETH, Director. Insider active across 1 companies, notably Epizyme, Inc.. Aggregated, 3 disclosures have been logged. The latest transaction was disclosed on 17 May 2022 — Attribution. Regulator: SEC (Form 4). All data is openly available.
Declarations3 total
08,994 shares0
Common Stock, par value $0.0001
SEC:0000899243-22-018843:0·
08,060 shares0
Common Stock, par value $0.0001
SEC:0000899243-21-023878·
08,060 shares0
Common Stock, par value $0.0001
SEC:0000899243-21-023878:0·
3 of 3 declarations
About BATE KENNETH
Kenneth Bate is a Board Member at Epizyme, Inc. He contributes to the governance of the company by participating in strategy formulation and critical decision-making. His experience in the industry is an asset to the board.
